Electrophysiological endophenotypes in rodent models of schizophrenia and psychosis

Biological Psychiatry

Volumn 77, Issue 12, 2015, Pages 1041-1049

  Rosen, Andrew M ^a   Spellman, Timothy ^a   Gordon, Joshua A ^a,b  

^a Columbia University ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

EEG; Excitation inhibition balance; Local field potentials; Oscillations; Schizophrenia; Synaptic plasticity

Indexed keywords

CLOZAPINE; DOPAMINE; DOPAMINE 4 RECEPTOR; DYSBINDIN; GLUTAMATE DECARBOXYLASE 67; METHYLAZOXYMETHANOL ACETATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT;

AUDITORY CORTEX; BRAIN ELECTROPHYSIOLOGY; BRAIN REGION; COGNITION; CONDITIONING; COPY NUMBER VARIATION; DNA REPLICATION; DOPAMINERGIC SYSTEM; ELECTRIC POTENTIAL; ELECTROENCEPHALOGRAPHY; ENDOPHENOTYPE; EVOKED AUDITORY RESPONSE; EVOKED RESPONSE; GENE MUTATION; GENETIC MODEL; GENETIC SUSCEPTIBILITY; GLUTAMATERGIC SYNAPSE; HIPPOCAMPUS; HUMAN; INTERNEURON; LONG TERM POTENTIATION; MAGNETOENCEPHALOGRAPHY; MEDIAL PREFRONTAL CORTEX; MINIATURE ENDPLATE POTENTIAL; MOUSE MODEL; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; OSCILLATION; PENETRANCE; POSTSYNAPTIC DENSITY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PSYCHOSIS; PYRAMIDAL NERVE CELL; REVIEW; RISK FACTOR; RODENT MODEL; SCHIZOPHRENIA; SENSORY GATING; SIGNAL NOISE RATIO; SKILL; WORKING MEMORY; ANIMAL; BRAIN; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; NERVE CELL INHIBITION; PATHOPHYSIOLOGY; PSYCHOLOGY; RAT;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; ENDOPHENOTYPES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEURAL INHIBITION; PSYCHOTIC DISORDERS; RATS; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84929697247     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2015.03.021     Document Type: Review

References (130)

1. D. Malaspina, S. Harlap, S. Fennig, D. Heiman, D. Nahon, D. Feldman, and E.S. Susser Advancing paternal age and the risk of schizophrenia Arch Gen Psychiatry 58 2001 361 367
2. S. Ripke, C. O'Dushlaine, K. Chambert, J.L. Moran, A.K. Kähler, and S. Akterin Genome-wide association analysis identifies 13 new risk loci for schizophrenia Nat Genet 45 2013 1150 1159
3. T. Spellman, and J. Gordon Synchrony in schizophrenia: A window into circuit-level pathophysiology Curr Opin Neurobiol 30 2015 17 23
4. D. Voineskos, N. Rogasch, T. Rajji, P. Fitzgerald, and Z.J. Daskalakis A review of evidence linking disrupted neural plasticity to schizophrenia Can J Psychiatry 58 2013 86 92
5. M. Beneyto, and D. Lewis Insights into the neurodevelopmental origin of schizophrenia from postmortem studies of prefrontal cortical circuitry Int J Dev Neurosci 29 2011 295 304
6. S.J. Fung, M. Webster, S. Sivagnanasundaram, C. Duncan, M. Elashoff, and C. Weickert Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia Am J Psychiatry 167 2010 1479 1488
7. G. Reynolds, Z. Abdul-Monim, J. Neill, and Z.J. Zhang Calcium binding protein markers of GABA deficits in schizophrenia - postmortem studies and animal models Neurotox Res 6 2004 57 61
8. E. Canu, F. Agosta, and M. Filippi A selective review of structural connectivity abnormalities of schizophrenic patients at different stages of the disease Schizophr Res 161 2015 19 28
9. P. Uhlhaas, and W. Singer High-frequency oscillations and the neurobiology of schizophrenia Dialogues Clin Neurosci 15 2013 301 313
10. T. Onitsuka, N. Oribe, I. Nakamura, and S. Kanba Review of neurophysiological findings in patients with schizophrenia Psychiatry Clin Neurosci 67 2013 461 470
11. A. Hasan, P. Falkai, and T. Wobrock Transcranial brain stimulation in schizophrenia: Targeting cortical excitability, connectivity and plasticity Curr Med Chem 20 2013 405 413
12. S. Schwab, and D. Wildenauer Genetics of psychiatric disorders in the GWAS era: An update on schizophrenia Eur Arch Psychiatry Clin Neurosci 263 2013 S147 S154
13. C. O'Tuathaigh, D. Babovic, G. O'Meara, J. Clifford, D. Croke, and J. Waddington Susceptibility genes for schizophrenia: Characterisation of mutant mouse models at the level of phenotypic behaviour Neurosci Biobehav Rev 31 2007 60 78
14. M. Kvajo, H. McKellar, and J. Gogos Molecules, signaling, and schizophrenia Curr Top Behav Neurosci 4 2010 629 656
15. R. Levy, B. Xu, J. Gogos, and M. Karayiorgou Copy number variation and psychiatric disease risk Methods Mol Biol 838 2012 97 113
16. B. Xu, J.L. Roos, S. Levy, E.J. van Rensburg, J. Gogos, and M. Karayiorgou Strong association of de novo copy number mutations with sporadic schizophrenia Nat Genet 40 2008 880 885
17. J. Chubb, N. Bradshaw, D. Soares, D. Porteous, and J. Millar The DISC locus in psychiatric illness Mol Psychiatry 13 2008 36 64
18. N. Allen, S. Bagade, M. McQueen, J. Loannidis, F. Kavvoura, and M. Khoury Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database Nat Genet 40 2008 827 834
19. Schizophrenia Working Group of the Psychiatric Genomics Consortium Biological insights from 108 schizophrenia-associated genetic loci Nature 511 2014 421 427
20. K.C. Murphy, L.A. Jones, and M.J. Owen High rates of schizophrenia in adults with velo-cardio-facial syndrome Arch Gen Psychiatry 56 1999 940 945
21. A.S. Bassett, C.R. Marshall, A.C. Lionel, E.W. Chow, and S.W. Scherer Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome Hum Mol Genet 17 2008 4045 4053
22. M. Karayiorgou, T. Simon, and J. Gogos 22q11.2 microdeletions: Linking DNA structural variation to brain dysfunction and schizophrenia Nat Rev Neurosci 11 2010 402 416
23. K. Stark, B. Xu, A. Bagchi, W. Lai, H. Liu, and R. Hsu Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model Nat Genet 40 2008 751 760
24. S. Chun, J. Westmoreland, I. Bayazitov, D. Eddins, A. Pani, and R. Smeyne Specific disruption of thalamic inputs to the auditory cortex in schizophrenia models Science 344 2014 1178 1182
25. T. Sigurdsson, K. Stark, M. Karayiorgou, J. Gogos, and J. Gordon Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia Nature 464 2010 763 767
26. L. Drew, K. Stark, K. Fénelon, M. Karayiorgou, A. Macdermott, and J. Gogos Evidence for altered hippocampal function in a mouse model of the human 22q11.2 microdeletion Mol Cell Neurosci 47 2011 293 305
27. S. Floresco, J. Seamans, and A. Phillips Selective roles for hippocampal, prefrontal cortical, and ventral striatal circuits in radial-arm maze tasks with or without a delay J Neurosci 17 1997 1880 1890
28. M. Jones, and M. Wilson Theta rhythms coordinate hippocampal-prefrontal interactions in a spatial working memory task PLoS Biol 2 2005 e402
29. R. Hsu, C.M. Schofield, C.G. Dela Cruz, D.M. Jones-Davis, R. Blelloch, and E.M. Ullian Loss of microRNAs in pyramidal neurons leads to specific changes in inhibitory synaptic transmission in the prefrontal cortex Mol Cell Neurosci 50 2012 283 292
30. C.M. Schofield, R. Hsu, A.J. Barker, C.C. Gertz, R. Blelloch, and E.M. Ullian Monoallelic deletion of the microRNA biogenesis gene Dgcr8 produces deficits in the development of excitatory synaptic transmission in the prefrontal cortex Neural Dev 6 2011 11
31. L.R. Earls, R.G. Fricke, J. Yu, R.B. Berry, L.T. Baldwin, and S.S. Zakharenko Age-dependent microRNA control of synaptic plasticity in 22q11 deletion syndrome and schizophrenia J Neurosci 32 2012 14132 14144
32. L. Desbonnet, O. Tighe, M. Karayiorgou, J. Gogos, J. Waddington, and C. O'Tuathaigh Physiological and behavioural responsivity to stress and anxiogenic stimuli in COMT-deficient mice Behav Brain Res 228 2012 351 358
33. J. Mukai, A. Dhilla, L. Drew, K. Stark, L. Cao, and A. MacDermott Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion Nat Neurosci 11 2008 1302 1310
34. M. Paterlini, S. Zakharenko, W. Lai, J. Qin, H. Zhang, and J. Mukai Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice Nat Neurosci 8 2005 1586 1594
35. K. Stark, R. Burt, J. Gogos, and M. Karayiorgou Analysis of prepulse inhibition in mouse lines overexpressing 22q11.2 orthologues Int J Neuropsychopharmacol 12 2009 983 989
36. H. Stefansson, D. Rujescu, S. Cichon, O.P. Pietiläinen, A. Ingason, and S. Steinberg Large recurrent microdeletions associated with schizophrenia Nature 455 2008 232 236
37. S. Stephens, A. Franks, R. Berger, M. Palionyte, T. Fingerlin, and B. Wagner Multiple genes in the 15q13-q14 chromosomal region are associated with schizophrenia Psychiatr Genet 22 2012 1 14
38. R. Bates, B. Stith, K. Stevens, and C. Adams Reduced Chrna7 expression in C3H mice is associated with increases in hippocampal parvalbumin and glutamate decarboxylase-67 (GAD67) as well as altered levels of GABAA receptor subunits Neuroscience 273 2014 52 64
39. K. Fejgin, J. Nielsen, M. Birknow, J. Bastlund, V. Nielsen, and J. Lauridsen A mouse model that recapitulates cardinal features of the 15q13.3 microdeletion syndrome including schizophrenia- and epilepsy-related alterations Biol Psychiatry 76 2014 128 137
40. M. Gandal, J. Edgar, K. Klook, and S. Siegel Gamma synchrony: Towards a translational biomarker for the treatment-resistant symptoms of schizophrenia Neuropharmacology 62 2012 1504 1518
41. Y. Liu, C. Fann, C. Liu, W. Chen, J. Wu, and S. Hung A single nucleotide polymorphism fine mapping study of chromosome 1q42.1 reveals the vulnerability genes for schizophrenia, GNPAT and DISC1: Association with impairment of sustained attention Biol Psychiatry 60 2006 554 562
42. W. Song, W. Li, K. Noltner, J. Yan, E. Green, and D. Grozeva Identification of high risk DISC1 protein structural variants in patients with bipolar spectrum disorder Neurosci Lett 486 2010 136 140
43. T. Nabeshima, and H. Kim Involvement of genetic and environmental factors in the onset of depression Exp Neurobiol 22 2013 235 243
44. H. Kilpinen, T. Ylisaukko-Oja, W. Hennah, O. Palo, T. Varilo, and R. Vanhala Association of DISC1 with autism and Asperger syndrome Mol Psychiatry 13 2008 187 196
45. A. Kamiya, K. Kubo, T. Tomoda, M. Takaki, R. Youn, and Y. Ozeki A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development Nat Cell Biol 7 2005 1167 1178
46. F. Lee, M. Fadel, K. Preston-Maher, S. Cordes, S. Clapcote, and D. Price Disc1 point mutations in mice affect development of the cerebral cortex J Neurosci 31 2011 3197 3206
47. C.A. Booth, J.T. Brown, and A.D. Randall Neurophysiological modification of CA1 pyramidal neurons in a transgenic mouse expressing a truncated form of disrupted-in-schizophrenia 1 Eur J Neurosci 39 2014 1074 1090
48. T. Cash-Padgett, and H. Jaaro-Peled DISC1 mouse models as a tool to decipher gene-environment interactions in psychiatric disorders Front Behav Neurosci 7 2013 113
49. M. Kvajo, H. McKellar, P. Arguello, L. Drew, H. Moore, and A. MacDermott A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition Proc Natl Acad Sci U S A 105 2008 7076 7081
50. M. Kvajo, H. McKellar, L. Drew, A. Lepagnol-Bestel, L. Xiao, and R. Levy Altered axonal targeting and short-term plasticity in the hippocampus of Disc1 mutant mice Proc Natl Acad Sci U S A 108 2011 E1349 E1358
51. K. Fénelon, J. Mukai, B. Xu, P. Hsu, L. Drew, and M. Karayiorgou Deficiency of Dgcr8, a gene disrupted by the 22q11.2 microdeletion, results in altered short-term plasticity in the prefrontal cortex Proc Natl Acad Sci U S A 108 2011 4447 4452
52. K. Fénelon, B. Xu, C. Lai, J. Mukai, S. Markx, and K. Stark The pattern of cortical dysfunction in a mouse model of a schizophrenia-related microdeletion J Neurosci 33 2013 14825 14839
53. B. Kirkpatrick, L. Xu, N. Cascella, Y. Ozeki, A. Sawa, and R. Roberts DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex J Comp Neurol 497 2006 436 450
54. K. Talbot, D.S. Cho, W.Y. Ong, M.A. Benson, L.Y. Han, and H.A. Kazi Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin Hum Mol Genet 15 2006 3041 3054
55. X. Chen, Y.Q. Feng, C.J. Hao, X.L. Guo, X. He, and Z.Y. Zhou DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release J Cell Biol 181 2008 791 801
56. J. Jentsch, H. Trantham-Davidson, C. Jairl, M. Tinsley, T.D. Cannon, and A. Lavin Dysbindin modulates prefrontal cortical glutamatergic circuits and working memory function in mice Neuropsychopharmacology 34 2009 2601 2608
57. Y. Ji, F. Yang, F. Papaleo, H.X. Wang, W.J. Gao, D.R. Weinberger, and B. Lu Role of dysbindin in dopamine receptor trafficking and cortical GABA function Proc Natl Acad Sci U S A 106 2009 19593 19598
58. G. Carlson, K. Talbot, T. Halene, M. Gandal, H. Kazi, and L. Schlosser Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia Proc Natl Acad Sci U S A 108 2011 E962 E970
59. W.B. Glen Jr, B. Horowitz, G.C. Carlson, T.D. Cannon, K. Talbot, J.D. Jentsch, and A. Lavin Dysbindin-1 loss compromises NMDAR-dependent synaptic plasticity and contextual fear conditioning Hippocampus 24 2014 204 213
60. A. Fisahn, J. Neddens, L. Yan, and A. Buonanno Neuregulin-1 modulates hippocampal gamma oscillations: Implications for schizophrenia Cereb Cortex 19 2009 612 618
61. H. Tamura, M. Kawata, S. Hamaguchi, Y. Ishikawa, and S. Shiosaka Processing of neuregulin-1 by neuropsin regulates GABAergic neuron to control neural plasticity of the mouse hippocampus J Neurosci 32 2012 12657 12672
62. L. Mei, and K. Nave Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases Neuron 83 2014 27 49
63. A.J. Law Genetic mouse models of neuregulin 1: Gene dosage effects, isoform-specific functions, and relevance to schizophrenia Biol Psychiatry 76 2014 89 90
64. L. Jiang, J. Emmetsberger, D.A. Talmage, and L.W. Role Type III neuregulin 1 is required for multiple forms of excitatory synaptic plasticity of mouse cortico-amygdala circuits J Neurosci 33 2013 9655 9666
65. M.J. Nason, A. Adhikari, M. Bozinoski, J. Gordon, and L. Role Disrupted activity in the hippocampal-accumbens circuit of type III neuregulin 1 mutant mice Neuropsychopharmacology 36 2011 488 496
66. I.H. Deakin, W. Nissen, A.J. Law, T. Lane, R. Kanso, and M.H. Schwab Transgenic overexpression of the type I isoform of neuregulin 1 affects working memory and hippocampal oscillations but not long-term potentiation Cereb Cortex 22 2012 1520 1529
67. X.J. Hou, K.M. Ni, J.M. Yang, and X.M. Li Neuregulin 1/ErbB4 enhances synchronized oscillations of prefrontal cortex neurons via inhibitory synapses Neuroscience 261 2014 107 117
68. R. Brisch, A. Saniotis, R. Wolf, H. Bielau, H.G. Bernstein, and J. Steiner The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: Old fashioned, but still in vogue Front Psychiatry 5 2014 47
69. K.N. Boyd, and R.B. Mailman Dopamine receptor signaling and current and future antipsychotic drugs Handb Exp Pharmacol 212 2012 53 86
70. M. Laruelle, A. Abi-Dargham, R. Gil, L. Kegeles, and R. Innis Increased dopamine transmission in schizophrenia: Relationship to illness phases Biol Psychiatry 46 1999 56 72
71. P. Seeman Schizophrenia and dopamine receptors Eur Neuropsychopharmacol 23 2013 999 1009
72. C. Kellendonk, E. Simpson, H. Polan, G. Malleret, S. Vronskaya, and V. Winiger Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning Neuron 49 2006 603 615
73. Y. Li, C. Kellendonk, E. Simpson, E. Kandel, and W. Gao D2 receptor overexpression in the striatum leads to a deficit in inhibitory transmission and dopamine sensitivity in mouse prefrontal cortex Proc Natl Acad Sci U S A 108 2011 12107 12112
74. J. Krystal, L. Karper, J. Seibyl, G. Freeman, R. Delaney, and J. Bremner Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses Arch Gen Psychiatry 51 1994 199 214
75. A. Lahti, B. Koffel, D. LaPorte, and C. Tamminga Subanesthetic doses of ketamine stimulate psychosis in schizophrenia Neuropsychopharmacology 13 1995 9 19
76. N. Dawson, B. Morris, and J. Pratt Subanaesthetic ketamine treatment alters prefrontal cortex connectivity with thalamus and ascending subcortical systems Schizophr Bull 39 2013 366 377
77. N. Dawson, X. Xiao, M. McDonald, D. Higham, B. Morris, and J. Pratt Sustained NMDA receptor hypofunction induces compromised neural systems integration and schizophrenia-like alterations in functional brain networks Cereb Cortex 24 2014 452 464
78. R. Moran, M. Jones, A. Blockeel, R.A. Adams, K. Stephan, and K. Friston Losing control under ketamine: Suppressed cortico-hippocampal drive following acute ketamine in rats Neuropsychopharmacology 40 2015 268 277
79. M. Lazarewicz, R. Ehrlichman, C. Maxwell, M. Gandal, L. Finkel, and S. Siegel Ketamine modulates theta and gamma oscillations J Cogn Neurosci 22 2010 1452 1464
80. J. McNally, R. McCarley, J. McKenna, Y. Yanagawa, and R. Brown Complex receptor mediation of acute ketamine application on in vitro gamma oscillations in mouse prefrontal cortex: Modeling gamma band oscillation abnormalities in schizophrenia Neuroscience 199 2011 51 63
81. D. Pinault N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex Biol Psychiatry 63 2008 730 735
82. Y. Zhang, T. Yoshida, D. Katz, and J. Lisman NMDAR antagonist action in thalamus imposes δ oscillations on the hippocampus J Neurophysiol 107 2012 3181 3189
83. B. Clementz, S. Sponheim, W. Iacono, and M. Beiser Resting EEG in first-episode schizophrenia patients, bipolar psychosis patients, and their first-degree relatives Psychophysiology 31 1994 486 494
84. D. Manahan-Vaughan, D. von Haebler, C. Winter, G. Juckel, and U. Heinemann A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats Hippocampus 18 2008 125 134
85. L.C. Amann, T.B. Halene, R.S. Ehrlichman, S.N. Luminais, N. Ma, T. Abel, and S.J. Siegel Chronic ketamine impairs fear conditioning and produces long-lasting reductions in auditory evoked potentials Neurobiol Dis 35 2009 311 317
86. J.A. Saunders, M.J. Gandal, and S.J. Siegel NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia Neurobiol Dis 46 2012 93 100
87. A. Brown The environment and susceptibility to schizophrenia Prog Neurobiol 93 2011 23 58
88. A. Schmitt, B. Malchow, A. Hasan, and P. Falkai The impact of environmental factors in severe psychiatric disorders Front Neurosci 8 2014 19
89. S.E. Canetta, and A.S. Brown Prenatal infection, maternal immune activation, and risk for schizophrenia Transl Neurosci 3 2012 320 327
90. D. Dickerson, A. Wolff, and D. Bilkey Abnormal long-range neural synchrony in a maternal immune activation animal model of schizophrenia J Neurosci 30 2010 12424 12431
91. G. Ducharme, G.C. Lowe, R. Goutagny, and S. Williams Early alterations in hippocampal circuitry and theta rhythm generation in a mouse model of prenatal infection: Implications for schizophrenia PLoS One 7 2012 e29754
92. D.D. Dickerson, K.A. Overeem, A.R. Wolff, J.M. Williams, W.C. Abraham, and D.K. Bilkey Association of aberrant neural synchrony and altered GAD67 expression following exposure to maternal immune activation, a risk factor for schizophrenia Transl Psychiatry 4 2014 e418
93. S. Savanthrapadian, A.R. Wolff, B.J. Logan, M.J. Eckert, D.K. Bilkey, and W.C. Abraham Enhanced hippocampal neuronal excitability and LTP persistence associated with reduced behavioral flexibility in the maternal immune activation model of schizophrenia Hippocampus 23 2013 1395 1409
94. C. O'Leary, L. Desbonnet, N. Clarke, E. Petit, O. Tighe, and D. Lai Phenotypic effects of maternal immune activation and early postnatal milieu in mice mutant for the schizophrenia risk gene neuregulin-1 Neuroscience 277 2014 294 305
95. B. Lipska, G. Jaskiw, and D. Weinberger Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: A potential animal model of schizophrenia Neuropsychopharmacology 9 1993 67 75
96. M.A. McDannald, J.P. Whitt, G.G. Calhoon, P.T. Piantadosi, R.M. Karlsson, P. O'Donnell, and G. Schoenbaum Impaired reality testing in an animal model of schizophrenia Biol Psychiatry 70 2011 1122 1126
97. K.Y. Tseng, R.A. Chambers, and B.K. Lipska The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia Behav Brain Res 204 2009 295 305
98. G. Le Pen, and J. Moreau Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: Reversal by clozapine, olanzapine and risperidone but not by haloperidol Neuropsychopharmacology 27 2002 1 11
99. J. François, A. Ferrandon, E. Koning, M. Angst, G. Sandner, and A. Nehlig Selective reorganization of GABAergic transmission in neonatal ventral hippocampal-lesioned rats Int J Neuropsychopharmacol 12 2009 1097 1110
100. P. O'Donnell, B. Lewis, D. Weinberger, and B. Lipska Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons in adult rats Cereb Cortex 12 2002 975 982
101. K. Tseng, B. Lewis, T. Hashimoto, S. Sesack, M. Kloc, D. Lewis, and P. O'Donnell A neonatal ventral hippocampal lesion causes functional deficits in adult prefrontal cortical interneurons J Neurosci 28 2008 12691 12699
102. C. Feleder, K.Y. Tseng, G.G. Calhoon, and P. O'Donnell Neonatal intrahippocampal immune challenge alters dopamine modulation of prefrontal cortical interneurons in adult rats Biol Psychiatry 67 2010 386 392
103. J.L. Vohs, R.A. Chambers, G.P. Krishnan, B.F. O'Donnell, W.P. Hetrick, and S.T. Kaiser Auditory sensory gating in the neonatal ventral hippocampal lesion model of schizophrenia Neuropsychobiology 60 2009 12 22
104. D. Rice, and S. Barone Jr Critical periods of vulnerability for the developing nervous system: Evidence from humans and animal models Environ Health Perspect 108 suppl 3 2000 511 533
105. D.J. Lodge, and A.A. Grace Gestational methylazoxymethanol acetate administration: A developmental disruption model of schizophrenia Behav Brain Res 204 2009 306 312
106. H. Moore, J.D. Jentsch, M. Ghajarnia, M.A. Geyer, and A.A. Grace A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: Implications for the neuropathology of schizophrenia Biol Psychiatry 60 2006 253 264
107. Y. Goto, and A. Grace Alterations in medial prefrontal cortical activity and plasticity in rats with disruption of cortical development Biol Psychiatry 60 2006 1259 1267
108. D.J. Lodge, M.M. Behrens, and A.A. Grace A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia J Neurosci 29 2009 2344 2354
109. T.M. Sanderson, M.C. Cotel, M.J. O'Neill, M.D. Tricklebank, G.L. Collingridge, and E. Sher Alterations in hippocampal excitability, synaptic transmission and synaptic plasticity in a neurodevelopmental model of schizophrenia Neuropharmacology 62 2012 1349 1358
110. P. Belujon, M.H. Patton, and A.A. Grace Disruption of prefrontal cortical-hippocampal balance in a developmental model of schizophrenia: Reversal by sulpiride Int J Neuropsychopharmacol 16 2013 507 512
111. P. Belujon, M.H. Patton, and A.A. Grace Role of the prefrontal cortex in altered hippocampal-accumbens synaptic plasticity in a developmental animal model of schizophrenia Cereb Cortex 24 2014 968 977
112. S. Singh, A. Kumar, S. Agarwal, S. Phadke, and Y. Jaiswal Genetic insight of schizophrenia: Past and future perspectives Gene 535 2014 97 100
113. L. Mrzljak, C. Bergson, M. Pappy, R. Huff, R. Levenson, and P. Goldman-Rakic Localization of dopamine D4 receptors in GABAergic neurons of the primate brain Nature 16 1996 245 248
114. S. Kapur, and G. Remington Atypical antipsychotics: New directions and new challenges in the treatment of schizophrenia Annu Rev Med 52 2001 503 517
115. E. Yuen, and Z. Yan Dopamine D4 receptors regulate AMPA receptor trafficking and glutamatergic transmission in GABAergic interneurons of prefrontal cortex J Neurosci 29 2009 550 562
116. M. Laruelle, L. Kegeles, and A. Abi-Dargham Glutamate, dopamine, and schizophrenia: From pathophysiology to treatment Ann N Y Acad Sci 1003 2003 138 158
117. K. Friston Schizophrenia and the disconnection hypothesis Acta Psychiatr Scand Suppl 395 1999 68 79
118. S. Lawrie, C. Buechel, H. Whalley, C. Frith, K. Friston, and E. Johnstone Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations Biol Psychiatry 51 2002 1008 1011
119. V.S. Sohal Insights into cortical oscillations arising from optogenetic studies Biol Psychiatry 71 2012 1039 1045
120. M.A. Whittington, and R.D. Traub Interneuron diversity series: Inhibitory interneurons and network oscillations in vitro Trends Neurosci 26 2003 676 682
121. G. Buzsaki, and B.O. Watson Brain rhythms and neural syntax: Implications for efficient coding of cognitive content and neuropsychiatric disease Dialogues Clin Neurosci 14 2012 345 367
122. M.S. Barr, F. Farzan, L.C. Tran, R. Chen, P.B. Fitzgerald, and Z.J. Daskalakis Evidence for excessive frontal evoked gamma oscillatory activity in schizophrenia during working memory Schizophr Res 121 2010 146 152
123. C. Schmiedt, A. Brand, H. Hildebrandt, and C. Basar-Eroglu Event-related theta oscillations during working memory tasks in patients with schizophrenia and healthy controls Brain Res Cogn Brain Res 25 2005 936 947
124. A.H. Neuhaus, F.C. Popescu, C. Grozea, E. Hahn, C. Hahn, and C. Opgen-Rhein Single-subject classification of schizophrenia by event-related potentials during selective attention Neuroimage 55 2011 514 521
125. N.N. Boutros, A. Mucci, A. Vignapiano, and S. Galderisi Electrophysiological abberations associated with negative symptoms in schizophrenia Curr Top Behav Neurosci 21 2014 129 156
126. F. Guenole, E. Chevrier, E. Stip, and R. Godbout A microstructural study of sleep instability in drug-naive patients with schizophrenia and healthy controls: Sleep spindles, rapid eye movements, and muscle atonia Schizophr Res 155 2014 31 38
127. J.A. Cardin, M. Carlen, K. Meletis, U. Knoblich, F. Zhang, and K. Deisseroth Driving fast-spiking cells induces gamma rhythm and controls sensory responses Nature 459 2009 663 667
128. M. Carlen, K. Meletis, J.H. Siegle, J.A. Cardin, K. Futai, and D. Vierling-Claassen A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior Mol Psychiatry 17 2012 537 548
129. V.S. Sohal, F. Zhang, O. Yizhar, and K. Deisseroth Parvalbumin neurons and gamma rhythms enhance cortical circuit performance Nature 459 2009 698 702
130. J. Yamamoto, J. Suh, D. Takeuchi, and S. Tonegawa Successful execution of working memory linked to synchronized high-frequency gamma oscillations Cell 157 2014 845 857